Skip to main navigation

News & Events Publications Patient Resources Contact

About Us
Science
- HBV Assets
  - Imdusiran (AB-729)
  - AB-101
Pipeline
Partnering
Investors
Culture & Careers

Investor Relations

Investor Center
Stock Information
Financial Information
Corporate Governance
Press Releases
Events & Presentations
Investor FAQ
Contact Us

Events & Presentations

Presentations

Arbutus Biopharma Corporate Presentation - November 2025

Events

Arbutus Tender Offer

Aug 24 - Sep 29, 2026

Schedule TO-I 43.3 KB

Offer to Purchase dated August 24 2026 together with the Issuer Bid Circular 367.2 KB

Form of Letter of Transmittal (including IRS Form W-9 and Form NR-301) 376.5 KB

Form of Notice of Guaranteed Delivery 68.1 KB

Letter to Brokers Dealers Banks Trust Companies and Other Nominees 64.6 KB

Letter to Clients for Use by Brokers Dealers Banks Trust Companies and Other Nominees 82.6 KB

Frequently Asked Questions for Employees dated August 24 2026 39.1 KB

Instructions to Shareworks Participants 26.8 KB

Material Change Report dated August 24 2026 230.6 KB

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share 105.3 KB

Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer 22.5 KB

Archived Events

Court Opinion Claim Construction Hearing

Apr 03, 2024

Court Opinion Claim Construction Hearing 540 KB

Complaint for Patent Infringement Against Pfizer/BioNTech

Apr 04, 2023

Filed Complaint 722.8 KB

Complaint for Patent Infringement Against Moderna

Feb 28, 2022

Filed Complaint 463 KB

Shareholder Tools

Email Alerts Email Alerts
RSS News Feeds RSS News Feeds
Download Library Download Library

© 2026 Arbutus Biopharma